Free Trial

ResMed (RMD) Short Interest Ratio & Short Volume

ResMed logo
$284.23 +4.06 (+1.45%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$285.87 +1.64 (+0.58%)
As of 08/8/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ResMed Short Interest Data

ResMed (RMD) has a short interest of 9.38 million shares. This marks a -7.40% decrease in short interest from the previous month. The short interest ratio (days to cover) is 10.4, indicating that it would take 10.4 days of the average trading volume of 1.15 million shares to cover all short positions.

Current Short Interest
9,380,000 shares
Previous Short Interest
10,130,000 shares
Change Vs. Previous Month
-7.40%
Dollar Volume Sold Short
$2.36 billion
Short Interest Ratio
10.4 Days to Cover
Last Record Date
July 15, 2025
Outstanding Shares
146,630,000 shares
Percentage of Shares Shorted
6.40%
Today's Trading Volume
827,364 shares
Average Trading Volume
1,149,579 shares
Today's Volume Vs. Average
72%
Short Selling ResMed?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for ResMed and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RMD Short Interest Over Time

RMD Days to Cover Over Time

RMD Percentage of Float Shorted Over Time

ResMed Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/20259,380,000 shares $2.36 billion -7.4%N/A10.4 $251.98
6/30/202510,130,000 shares $2.62 billion +2.0%7.0%10.2 $258.24
6/15/20259,930,000 shares $2.47 billion -6.2%6.8%9.8 $249.16
5/31/202510,590,000 shares $2.59 billion -3.1%7.3%10 $244.62
5/15/202510,930,000 shares $2.72 billion +15.9%7.5%9.9 $248.60
4/30/20259,430,000 shares $2.23 billion +3.5%N/A8.9 $236.49
4/15/20259,110,000 shares $1.95 billion +2.4%6.2%8.1 $213.98
3/31/20258,900,000 shares $1.99 billion +2.0%6.1%8.7 $223.81
3/15/20258,730,000 shares $1.96 billion No Change6.0%9.1 $224.48
2/28/20258,730,000 shares $2.04 billion -10.1%6.0%9.4 $233.32
2/15/20259,710,000 shares $2.26 billion +17.0%6.7%11.2 $232.93
1/31/20258,300,000 shares $1.96 billion +3.2%N/A9.6 $236.66
1/15/20258,040,000 shares $1.87 billion +1.6%N/A8.9 $233.01
12/31/20247,910,000 shares $1.81 billion +1.3%N/A8.9 $228.69
12/15/20247,810,000 shares $1.86 billion +3.6%N/A8.3 $238.52
11/30/20247,540,000 shares $1.88 billion +3.2%N/A7.8 $249.02
11/15/20247,310,000 shares $1.72 billion -7.4%N/A7.1 $234.77
10/31/20247,890,000 shares $1.91 billion -8.9%N/A7.7 $242.47
10/15/20248,660,000 shares $2.07 billion +1.1%N/A8.5 $239.18
9/30/20248,570,000 shares $2.09 billion -0.1%N/A8.6 $244.13
9/15/20248,580,000 shares $2.14 billion +0.4%N/A7.9 $248.93
8/31/20248,550,000 shares $2.09 billion -12.6%N/A7.9 $245.02
8/15/20249,780,000 shares $2.22 billion +9.9%N/A9.1 $227.26
7/31/20248,900,000 shares $1.90 billion +5.0%N/A8.4 $213.25
7/15/20248,480,000 shares $1.74 billion -1.2%N/A7.9 $205.31
6/30/20248,580,000 shares $1.64 billion +4.1%N/A7.6 $191.42
6/15/20248,240,000 shares $1.74 billion -16.5%N/A7.3 $211.73
5/31/20249,870,000 shares $2.04 billion -3.3%N/A9.2 $206.33
5/15/202410,210,000 shares $2.25 billion +3.7%N/A9.5 $220.63
4/30/20249,850,000 shares $2.11 billion +23.9%N/A9 $214.04
4/15/20247,950,000 shares $1.47 billion +0.8%N/A7.5 $185.09
3/31/20247,890,000 shares $1.56 billion +3.0%N/A7.8 $198.03
3/15/20247,660,000 shares $1.46 billion +13.3%N/A7.9 $190.10
2/29/20246,760,000 shares $1.17 billion +2.7%N/A7.4 $173.72
2/15/20246,580,000 shares $1.20 billion +4.0%N/A7.4 $182.64
1/31/20246,330,000 shares $1.20 billion +7.5%N/A6.5 $190.20
1/15/20245,890,000 shares $1.02 billion +3.9%N/A5.5 $173.90
12/31/20235,670,000 shares $975.35 million -2.4%N/A4.8 $172.02
12/15/20235,810,000 shares $982.18 million -0.7%N/A4.4 $169.05
11/30/20235,850,000 shares $922.72 million -7.3%N/A3.9 $157.73
Altucher: Trump’s Great Gain is starting (Ad)

New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.

See Altucher’s Trump crypto prediction here
11/15/20236,310,000 shares $960.07 million +10.3%N/A3.9 $152.15
10/31/20235,720,000 shares $807.78 million +18.4%N/A3.3 $141.22
10/15/20234,830,000 shares $677.41 million +1.5%N/A2.9 $140.25
9/30/20234,760,000 shares $703.86 million +24.6%N/A3.2 $147.87
9/15/20233,820,000 shares $555.39 million +20.9%N/A2.9 $145.39
8/31/20233,160,000 shares $504.30 million +110.7%N/A2.8 $159.59
8/15/20231,500,000 shares $275.03 million +19.1%N/A1.6 $183.35
7/31/20231,260,000 shares $280.16 million -5.3%N/A1.7 $222.35
7/15/20231,330,000 shares $295.73 million +11.8%N/A2.1 $222.35
6/30/20231,190,000 shares $260.02 million +15.5%N/A1.9 $218.50
6/15/20231,030,000 shares $225.42 million -28.5%N/A1.7 $218.85
5/31/20231,440,000 shares $303.54 million +38.5%N/A2.4 $210.79
5/15/20231,040,000 shares $241.79 million +2.0%N/A1.9 $232.49
4/30/20231,020,000 shares $245.78 million -11.3%N/A1.8 $240.96
4/15/20231,150,000 shares $258.24 million -19.0%N/A2 $224.56
3/31/20231,420,000 shares $310.97 million +9.2%1.0%2.3 $218.99
3/15/20231,300,000 shares $270.39 million +20.4%0.9%2 $207.99
2/28/20231,080,000 shares $230.04 million +1.9%0.7%1.7 $213.00
2/15/20231,060,000 shares $227.77 million +25.5%0.7%1.7 $214.88
1/31/2023844,900 shares $192.95 million -0.6%0.6%1.5 $228.37
1/15/2023850,000 shares $185.39 million -15.8%0.6%1.5 $218.10
12/30/20221,010,000 shares $210.21 million +6.3%0.7%1.8 $208.13
12/15/2022950,100 shares $204.31 million -5.9%0.7%1.8 $215.04
11/30/20221,010,000 shares $232.50 million -5.6%0.7%2 $230.20
11/15/20221,070,000 shares $239.28 million -18.3%0.7%2.2 $223.63
10/31/20221,310,000 shares $293.03 million +6.5%0.9%2.6 $223.69
10/15/20221,230,000 shares $260.45 million -8.2%0.9%2.6 $211.75
9/30/20221,340,000 shares $292.52 million -11.3%0.9%2.9 $218.30
9/15/20221,510,000 shares $341.18 million +18.0%1.0%3 $225.95
8/31/20221,280,000 shares $281.50 million -3.0%0.9%2.3 $219.92
8/15/20221,320,000 shares $312.99 million -28.3%0.9%2.4 $237.11
7/31/20221,840,000 shares $442.56 million +18.7%1.3%3.2 $240.52
7/15/20221,550,000 shares $349.53 million +11.5%1.1%2.5 $225.50
6/30/20221,390,000 shares $291.39 million -7.3%1.0%2.3 $209.63
6/15/20221,500,000 shares $304.92 million +15.4%1.0%2.5 $203.28
5/31/20221,300,000 shares $264.50 million -4.4%0.9%2.4 $203.46
5/15/20221,360,000 shares $267.73 million +5.4%0.9%2.4 $196.86
4/30/20221,290,000 shares $257.96 million -1.5%0.9%2.2 $199.97
4/15/20221,310,000 shares $306.82 million +6.5%0.9%2.2 $234.21
3/31/20221,230,000 shares $298.29 million +27.8%0.9%2 $242.51
3/15/2022962,200 shares $235.08 million -16.3%0.7%1.7 $244.31
2/28/20221,150,000 shares $283.76 million -8.0%0.8%2 $246.75
2/15/20221,250,000 shares $294.06 million +44.3%0.9%2.2 $235.25
1/31/2022866,400 shares $198.06 million +9.7%0.6%1.6 $228.60
1/15/2022790,100 shares $199.23 million +3.6%0.6%1.6 $252.16
12/31/2021762,800 shares $198.69 million +3.2%0.5%1.5 $260.48
12/15/2021739,000 shares $189.60 million -13.1%0.5%1.3 $256.56
11/30/2021850,600 shares $216.78 million -8.0%0.6%1.5 $254.85
11/15/2021924,400 shares $242.53 million -11.1%0.6%1.7 $262.37
10/29/20211,040,000 shares $273.43 million +8.8%0.7%2 $262.91
Altucher: Trump’s Great Gain is starting (Ad)

New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.

See Altucher’s Trump crypto prediction here
10/15/2021955,600 shares $244.15 million -2.5%0.7%1.9 $255.49
9/30/2021979,800 shares $258.23 million -10.1%0.7%2.1 $263.55
9/15/20211,090,000 shares $316.56 million No Change0.8%2.3 $290.42
8/31/20211,090,000 shares $316.68 million -11.4%0.8%2.1 $290.53
8/13/20211,230,000 shares $338.37 million +16.0%0.9%2.2 $275.10
7/30/20211,060,000 shares $288.11 million No Change0.7%1.8 $271.80
7/15/20211,060,000 shares $264.58 million -10.2%0.7%1.7 $249.60
6/30/20211,180,000 shares $290.89 million -16.3%0.8%1.9 $246.52
6/15/20211,410,000 shares $333.41 million -0.7%1.0%2.2 $236.46
5/28/20211,420,000 shares $292.31 million -9.0%1.0%2.4 $205.85
5/14/20211,560,000 shares $303.98 million +40.5%N/A2.5 $194.86
4/30/20211,110,000 shares $230.78 million -2.6%N/A1.6 $207.91
4/15/20211,140,000 shares $236.76 million +17.2%N/A1.7 $207.68
3/31/2021972,500 shares $184.10 million +5.6%N/A1.5 $189.31
3/15/2021920,600 shares $170.42 million -9.8%N/A1.4 $185.12
2/26/20211,020,000 shares $198.88 million -14.3%N/A1.7 $194.98
2/12/20211,190,000 shares $238.63 million +9.2%N/A2.1 $200.53
1/29/20211,090,000 shares $235.36 million +0.9%N/A2.1 $215.93
1/15/20211,080,000 shares $230.34 million No ChangeN/A2.3 $213.28
12/31/20201,080,000 shares $226.50 million -4.4%N/A2.3 $209.72
12/15/20201,130,000 shares $233.21 million -3.4%N/A2.3 $206.38
11/30/20201,170,000 shares $245.28 million -20.4%N/A2.3 $209.64
11/15/20201,470,000 shares $315.67 million +9.7%N/A2.9 $214.74
10/30/20201,340,000 shares $240.54 million -8.8%N/A2.4 $179.51
10/15/20201,470,000 shares $261.38 million -3.3%N/A2.5 $177.81
9/30/20201,520,000 shares $260.57 million +2.7%N/A2.6 $171.43
9/15/20201,480,000 shares $259.81 million -11.4%N/A2.4 $175.55
8/31/20201,670,000 shares $301.90 million +3.7%N/A2.5 $180.78
8/14/20201,610,000 shares $284.62 million -9.0%N/A2.3 $176.78

RMD Short Interest - Frequently Asked Questions

What is ResMed's current short interest?

Short interest is the volume of ResMed shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 9,380,000 shares of RMD short. Learn More on ResMed's current short interest.

What is a good short interest ratio for ResMed?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RMD shares currently have a short interest ratio of 10.0. Learn More on ResMed's short interest ratio.

Which institutional investors are shorting ResMed?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ResMed: Twin Tree Management LP, Baader Bank Aktiengesellschaft, Quaker Wealth Management LLC, Jane Street Group LLC, Select Equity Group L.P., Parallax Volatility Advisers L.P., Millennium Management LLC, Nomura Holdings Inc., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, and Citigroup Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is ResMed's short interest increasing or decreasing?

ResMed saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 9,380,000 shares, a decline of 7.4% from the previous total of 10,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does ResMed's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to ResMed: Medpace Holdings, Inc. (13.51%), Encompass Health Corporation (1.00%), Hims & Hers Health, Inc. (29.17%), Boston Scientific Corporation (1.32%), Stryker Corporation (1.33%), Medtronic PLC (1.02%), Becton, Dickinson and Company (1.64%), Edwards Lifesciences Corporation (1.20%), IDEXX Laboratories, Inc. (3.32%), DexCom, Inc. (2.27%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

What does it mean to sell short ResMed stock?

Short selling RMD is an investing strategy that aims to generate trading profit from ResMed as its price is falling. RMD shares are trading up $4.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ResMed?

A short squeeze for ResMed occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RMD, which in turn drives the price of the stock up even further.

How often is ResMed's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RMD, twice per month. The most recent reporting period available is July, 15 2025.




This page (NYSE:RMD) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners